BioCentury
ARTICLE | Financial News

Aslan raises $34M in series C round

December 8, 2015 2:33 AM UTC

Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $34 million in a series C round led by the Accuron Technologies Ltd. subsidiary of Temasek Holdings. New investors Tianda Pharmaceuticals Ltd. (Hong Kong, China) and Haitong International also participated, as did existing investors Morningside Group, BioVeda Capital, Cenova Ventures and Sagamore Bioventures. ...